Cancer Proteomics 2011: Systems Biology, Developmental Models and Data Integration



Download 42.1 Kb.
Date09.06.2018
Size42.1 Kb.
#53702
Cancer Proteomics 2011: Systems Biology, Developmental Models and Data Integration

Scientific program (draft)


Date and venue:

20th-23rd June 2011 - The Burlington Hotel, Upper Leeson Street, Dublin 4, Ireland


Primary conference organiser:

William Gallagher – UCD Conway Institute, University College Dublin, Ireland


Conference co-organisers:

Ruedi Aebersold – Institute for Molecular Systems Biology, ETH Zurich, Switzerland

Rolf Apweiler – European Bioinformatics Institute, UK

Ben Collins – Institute for Molecular Systems Biology, ETH Zurich, Switzerland

Connie Jimenez – VUMC-Cancer Center Amsterdam, Netherlands

Walter Kolch – Systems Biology Ireland, University College Dublin, Ireland

Tony Ng – King's College London, UK

Serhiy Souchelnytskyi – Karolinska Biomics Center, Sweden



Monday 20th June 2011

Educational Session - Integrated analysis of data analysis for cancer systems biology

Chairperson: Ben Collins


08.30-09.00 Registration (educational session)
09.00-09.40 Matthias Mann – Max Planck Institute for Biochemistry, Martinsried, Germany

“MaxQuant and Perseus for the bioinformatic analysis of quantitative proteome data”


09.40-10.20 Rolf Apweiler – European Bioinformatics Institute, Hinxton, UK

"Using proteomic data resources to identity novel cancer targets"


10.20-10.40 Coffee
10.40-11.20 Aedín Culhane – Dana-Farber Cancer Institute, Boston, USA

“Using curated gene information in statistical meta-analysis of genomics data”

11.20-12.00 Fredrik Ponten – Uppsala University, Sweden

“Using the Human Protein Atlas portal as a tool for finding protein expression patterns”


12.00-13.00 Lunch (educational session attendees only)
12.30-13.15 Registration (main program)

Session 1 - Quantitative proteomics in cancer systems biology I – cells and tissues

Chairperson: William Gallagher


13.20-13.30 Welcome and opening remarks (William Gallagher)
13.30-14.20 Opening Keynote Lecture: Matthias Mann – Max Planck Institute for Biochemistry, Martinsried, Germany

"Super-SILAC technology to accurately quantify the cancer proteome"


14.20-14.55 Fredrik Ponten – Uppsala University, Sweden

"A Human Protein Atlas for profiling normal and cancer cells and tissues"


14.55-15.20 Proffered Talk 1: Laoighse Mulrane – UCD Conway Institute, Dublin, Ireland

“MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer”


15.20-15.50 Coffee/Trade exhibit
15.50-16.25 Laura Beretta – Fred Hutchinson Cancer Research Center, Seattle, USA

" Comparative Proteomics Studies in Mouse Models of Hepatocellular Carcinoma"


16.25-17.00 Connie Jimenez – VUmc-Cancer Center Amsterdam, The Netherlands

"Proteomics of colorectal adenoma to carcinoma progression

to identify biomarkers for early detection of CRC"
17.00-17.25 Proffered Talk 2: Sara Zanivan – Beatson Institute for Cancer Research, Glasgow, United Kingdom

“In vivo quantitative proteomics and phosphoproteomics of skin cancer development”

(Abstract selected for emerging investigator award)
17.25-17.50 Proffered Talk 3: François-Michel Boisvert – University of Dundee, United Kingdom

“A quantitative spatial proteomics analysis of proteome turnover in human cancer cells”


17.50 Welcome Reception and Trade Exhibit

Tuesday 21st June 2011

Session 2 - Cancer stem cells and developmental model systems

Chairperson: Serhiy Souchelnytskyi


09.00-09.35 Tony Whetton – University of Manchester

“Proteomic studies on normal and leukaemic stem cells reveal novel regulatory pathways in drug responses”


09.35-10.10 Xiaoyan Jiang – University of British Columbia, Vancouver, Canada

“A novel AHI-1-BCR-ABL-JAK2 interaction complex mediates cellular resistance to tyrosine kinase inhibitors in chronic myeloid leukemia stem cells”


10.10-10.35 Proffered Talk 4: Leonie Norris – University of Leicester, United Kingdom

“A strategy for label-free quantification of protein biomarkers in cancer stem-like cells”


10.35-11.05 Coffee/Trade exhibit

11.05-11.40 Eileen Furlong – European Molecular Biology Laboratory, Heidelberg, Germany

“Transcriptional networks during development - Deciphering the code”
11.40-12.05 Proffered Talk 5: Veronica Miguela – Instituto de Neurociencias, Alicante, Spain

“Looking for new partners in crime for the tumorigenic activity of Pipsqueak”


12.05-12.50 Lunch/Trade exhibit

Poster Session 1

12.50-13.50 Authors of even numbered posters in attendance



Session 3 – Proffered talk session

Chairperson: William Gallagher


13.50-14.15 Proffered Talk 6: Safia Thaminy – Institute of Molecular Systems Biology, Zurich, Switzerland

“Integrated proteomic and siRNA screen analysis to study the migratory phenotype of breast cancer cell lines”

(Abstract selected for emerging investigator award)

14.15-14.40 Proffered Talk 7: Tamar Geiger – Max Planck Institute of Biochemistry, Martinsried, Germany

“A proteomic portrait of human breast cancer progression”
14.40-15.05 Proffered Talk 8: Bodo Lange – Max-Planck Institut für molekulare Genetik, Berlin, Germany

“Functional characterisation of a centrosome protein interaction network relating to centrosome biogenesis and aberration in cancer cells”


15.05-15.30 Proffered Talk 9: Adam Byron – University of Manchester, United Kinddom

“Proteomic analysis of integrin adhesion signalling in cancer cells”


15.30-15.55 Proffered Talk 10: Aaron Robitaille - Biozentrum, University of Basel, Switzerland

“Quantitative analysis of the mTOR signaling network”

(Abstract selected for emerging investigator award)
15.55-16.25 Coffee/Trade exhibit

Session 4 - Quantitative proteomics in cancer systems biology II – biofluids

Chairperson: Connie Jimenez


16.25-17.00 Stephen Pennington – University College Dublin, Ireland

“Cancer Proteomics: Promise or Progress?”


17.00-17.35 Michael Gillette – Broad Institute of MIT and Harvard, Cambridge, USA

“Progress toward a biomarker discovery-to-development pipeline in clinical proteomics”


17.35-18.10 Ruth Hüttenhain – Institute for Molecular Systems Biology, ETH Zurich, Switzerland

“Cancer genetics-guided discovery of protein biomarkers and their SRM-based verification in plasma”


18.10-18.35 Proffered Talk 11: Yue Fan – UCD Conway Institute, Dublin, Ireland

“Label-free LC-MS/MS and MRM development for discovery and verification of biomarkers for prostate cancer”




Wednesday 22nd June 2011
09.00-09.45 Address by Minister of State
Session 5 - Data integration I – Cellular signalling networks

Chairperson: Walter Kolch


09.45-10.20 Emmanuel Barillot – Institut Curie, Paris, France

"Modeling biological networks involved in tumor progression"


10.20-10.55 Rune Linding – Technical University of Denmark, Lyngby, Denmark

"Cancer network medicine and cellular information processing"


10.55-11.25 Coffee/Trade exhibit
11.25-12.00 Ulrike Eggert– Dana Farber Cancer Institute, Boston, USA

"A chemical approach to understanding cell division"


12.00-12.35 Christie Sers– Charité Universitätsmedizin Berlin, Germany

"Systems biology in predictive medicine"


12.35-13.25 Lunch/Trade exhibit
Poster Session 2

13.25-14.25 Authors of odd numbered posters in attendance


Session 6 - Protein complexes and protein-protein interaction networks

Chairperson: Tony Ng


14.25-15.00 Andrew Emili – University of Toronto, Toronto, Canada

"Interaction networks and chromatin-related protein complexes in cancer"


15.00-15.35 Walter Kolch– Systems Biology Ireland, Dublin, Ireland

“Signalling networks and systems biology”


15.35-16.10 Michael Cusick – Dana-Farber Cancer Institute, Boston, USA

"Interactome networks & human disease"


16.10-16.40 Coffee/Trade exhibit
16.40-17.15 Igor Stagljar – University of Toronto, Canada

"Protein interaction networks regulating cell signalling in cancer"


17.15-17.40 Proffered Talk 12: Anthony Coolen –King's College London, United Kingdom

“Non-equilibrium statistical mechanics of signalling in large protein interaction networks”


Conference Dinner and Entertainment

Thursday 23rd June 2011

Session 7 - Data integration II – global views of cancer processes

Chairperson: Rolf Apweiler


09.00-09.35 Søren Brunak– Technical University of Denmark, Kongens Lyngby, Denmark

“Integrating healthcare sector data with molecular data in cancer”


09.35-10.10 Anne-Lise Børresen-Dale The Norwegian Radium Hospital, Oslo, Norway

"Integrated genomics of breast cancer"


10.10-10.40 Coffee/Trade exhibit
10.40-11.15 Aedín Culhane – Dana-Farber Cancer Institute, Boston, USA

“Computational Discovery of the Hallmarks of Cancer through Meta Gene Set Analysis”


11.15-11.50 Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam, The Netherlands

“Oncogenic pathway identification through itegration of diverse, same sample data sources”


11.50-12.50 Lunch/Trade exhibit

Session 8 - Connecting systems approaches to commercial and clinical use

Chairperson: Stephen Pennington


12.50-13.25 Serhiy Souchelnytskyi – Karolinska Biomics Center, Stockholm, Sweden

"Personalized medicine and cancer proteomics"


13.25-14.00 Tony Ng - King's College London, UK

“Use of nanoscopic cancer tissue imaging, gene bioinformatics and mathematical modelling to predict the metastatic outcome of breast cancer sufferers“


14.00-14.25 Proffered Talk 13: Steven Kornblau – U. Texas M.D. Anderson Cancer Center, Houston, USA

“Proteomic analysis of the signaling pathways underlying acute myeloid leukemia”


14.25-14.55 Coffee/Trade exhibit
14.55-15.30 William Gallagher – University College Dublin, Dublin, Ireland

“Bridging the translational divide: converting omic datasets into clinical relevant assays”


15.30-16.20 Closing Keynote Lecture: Dario Neri – Institute of Pharmaceutical Sciences ETH Zurich, Switzerland

"Vascular tumor targeting: from target discovery to clinical trials"


16.20-16.25 Closing Remarks (William Gallagher)
Directory: cfs2-11-03

Download 42.1 Kb.

Share with your friends:




The database is protected by copyright ©ininet.org 2024
send message

    Main page